ProstaLund AB (publ) (STO:PLUN)
Sweden · Delayed Price · Currency is SEK 0.4260
-0.0360 (-7.79%)
Jul 18, 2025, 3:51 PM CET
ProstaLund AB Company Description
rostaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally.
It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow, a temporary prostate stent; Oruflow, a urine flow meter; and Schelin Catheter, a medical device intended for intraprostatic and periprostatic injection of legally market drugs.
Its products are used in hospitals and clinics. The company was founded in 1991 and is based in Lund, Sweden.
ProstaLund AB (publ) is a subsidiary of Farstorps Gard Forvaltnings AB.
ProstaLund AB (publ)
| Country | Sweden |
| Founded | 1991 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 9 |
| CEO | Malin Melander |
Contact Details
Address: Scheelevägen 19 Lund, 223 63 Sweden | |
| Phone | 46 46 12 09 08 |
| Website | prostalund.se |
Stock Details
| Ticker Symbol | PLUN |
| Exchange | Nasdaq Stockholm |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0002372318 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Malin Melander | Chief Operating Officer and Acting Chief Executive Officer |
| Annette Colin | Interim Chief Financial Officer |
| Johan Laven | Director of Sales and Marketing |